Howard T. Lee MD FAST
@HowardTLeeMD
Tzu-Hao Lee (He/Him) Txp Hepatologist/Asst. Professor @bcm_gihep #HBV #HCV #LT #HCC #MedEd #DEI @RainbowinGastro🏳️🌈Alumni: @Duke_GI @IMResidencyDuke #Taiwan
So proud of this very first review📜about Liver #Transplnt for 🏳️🌈#LGBTQ+ patients in 🇺🇸 Thanks to @LancetGastroHep for the opportunity to highlight this🔥topic & support from my co-authors @doctornikkid @4_kidney @DougSimonetto @spaulliver authors.elsevier.com/a/1hvNc8nByr8u… #LiverTwitter

Hi #LICOP family, are you presenting @WTCMeeting? 📢Please fill out the brief form by 8/1 Fri, and we will post it on X & Bluesky 📝redcap.link/LICOPWTC25 You can also post it yourself and tag us @AST_LICOP (X) or @ast-licop.bsky.social (BS)🫶 #LiverTwitter #WTC2025
Join us for the #LICOP events at #WTC2025🙌 🍸LICOP Night Out 📅 8/2 Sat 🕗 8–10 PM 📍 Novela – 662 Mission Street Just a 5-minute walk from Moscone Center! 👥LICOP Annual Meeting 📅 8/3 Sun 🕞 3:45–5 PM 📍 Room 152, Moscone Center #LiverTwitter @lindsayykingmd @HowardTLeeMD
Explore our #hepatitis research this #WorldHepatitisDay! Check out our curated hepatitis elimination article collection highlighting breakthroughs in treatment, prevention, & public health. 🔗 Explore the leading research now: journals.lww.com/aasldpubs/page… #LiverHealth #AASLD
🤖 AI in the endo suite isn’t the future—it’s now. Dr. @NMansourMD shares how to use CADe tools the right way, following AGA guidelines. 📺 Learn more in the full course package. Available here: bit.ly/3IvXvEt @bcm_gihep @FrontGastro_BMJ
📢Long-awaited CIRROXABAN is OUT! ➡️RCT ppx rivaroxaban, CP7:10, outcome death/tplt/decomp ➡️primary outcome 27% vs 47% (p=0.058) in AC ➡️similar bleeding, more nonpHTN bleeds in AC, RIV levels 100+ assoc w/bleeds ➡️kPa ⬇️ in AC group #livertwitter journal-of-hepatology.eu/article/S0168-…
Uncover how to differentiate #palliative care from #hospice in module 1 of Palliative Care and Advanced Liver Disease. Expand your expertise today! Start module 1 now: bit.ly/4l5moVX
🫀📊 New research reveals link between MASLD and undiagnosed heart failure. Time to rethink screening strategies. #MASLD #livertwitter @KWegermann @MaratFudim @DCRINews #NAFLD #HF
Drs. Kara Wegermann and Marat Fudim led a new study linking fatty liver disease (MASLD/NAFLD) to high rates of undiagnosed heart failure. Nearly 1 in 5 patients developed HF—and nearly half showed early signs. Findings underscore need for early screening. dcri.org/news/study-rev…
Milestone for Veteran care🎖️ @VAHouston becomes the first VA Pancreas Center of Excellence in 🇺🇸 Proud moment for #VeteransHealth 👏 ow.ly/JBCN50Wf6iL Grateful for the support & leadership @EndoscopyOthman @ruben_hernaez @SeragHashem @KanwalFasiha @BiykemB…
The Houston VA Pancreas Clinic has been designated by the National Pancreas Foundation as the first Center of Excellence for pancreas care within the VA system! ow.ly/JBCN50Wf6iL #HoustonVA
🎙️ Dr. @KanwalFasiha shares her expert insights on where the field is headed. Catch her talk: "The Future of Gastroenterology: What’s on the Horizon" only with BCM Clinician Resources bit.ly/3IvXvEt @SeragHashem @bcm_gihep @WasAbiDoc @tmcddc @TexasGastros @TexasIEG
Sharp insights, no fluff-- hear from @BCMDeptMedicine gastroenterologist Dr. Rollin George. The Encroachment of GLP-1: How it Affects the Practice of Gastroenterology here: bit.ly/3IvXvEt @bcm_gihep @Gut_BMJ @ruben_hernaez @TexasGastros @shifaumarMD
⚡Sharp data. Real impact. Dr. @GCholankeril's talk, "Defining MetALD and Its Treatment Approach" on BCM Clinician Resources: @LiverFellow @AmCollegeGastro @AASLDFoundation @JHepatology @AASLDtweets
📢 Registration is OPEN for the GI & LIVER Board Review Course! 🔍 Covering: •GI Diseases •Liver Disorders •Pancreaticobiliary Disease •IBD •Neuro-Gastroenterology & more 🗓️ Oct 11-12th 🎯Board-focused 🎯 Perfect for fellows & practicing GI docs 🎯 Virtual & in person 👉…
I am happy to announce @AmerGastroAssn @AASLDtweets @AmCollegeGastro We have TWO openings at @VAHouston- @BCMDeptMedicine @bcm_gihep We're awesome, simply apply- USAJOBS - Job Announcement usajobs.gov/job/841227000/…
Use Fibroscan liver stiffness + platelet count to document: ➡Clinically Significant Portal Hypertension (CSPH) ➡compensated Advanced Chronic Liver Disease (cACLD) Our Hepatology📰 shows the categories & rationale & argues for category of "critical" CSPH journals.lww.com/hep/fulltext/2…
A call for doubling the diagnostic rate of at-risk metabolic dysfunction-associated steatohepatitis @JVLazarus @TheLancet @geneyim @AlkhouriNaim pubmed.ncbi.nlm.nih.gov/40672054/
🗨️ “Vaccines have done more to improve public health than any other medical intervention.” A Viewpoint focuses on cancer vaccines and the future of immunotherapy—analysing trials, different vaccine approaches, and how the next generation of cancer vaccines can help improve…
I am very grateful to have been able to collaborate in this @TheLancet Seminar on Acute Liver Failure with @MaiwallRakhi @AnandVKulkarni2 @salvatore_piano Very important topic, hope you find it useful and informative 👉 Acute liver failure (ALF) is a life-threatening disorder…
Original Article Disparities in screening and risk stratification for Hispanic adults with metabolic dysfunction–associated steatotic liver disease Tincopa et al. #LiverX tinyurl.com/5yjr529a
Battle of the mini TIPS after Variceal bleeds 6mm v 8mm More rebleeding Less HE equal survival